David L. Cutler
- Molecular Biology top 10%
- Oncology top 5%
- Epidemiology top 5%
- Genetics top 1%
- Pulmonary and Respiratory Medicine top 5%
- Co-authors
- Paul StatkevichTeddy KosoglouMelton B. AffrimeLarisa ReydermanPascale ReidenbergEric K. RowinskyMargaret DuganElaine Radwanski
- Topics
- Cancer Treatment and Pharmacology (21 papers)Diabetes Treatment and Management (11 papers)Antiplatelet Therapy and Cardiovascular Diseases (10 papers)
- Cited by
- GeneticsHepatologyOncology
- Journals
- New England Journal of MedicineJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- United StatesArgentinaUnited Kingdom
In The Last Decade
David L. Cutler
145 papers receiving 3.7k citations
Peers
Comparison fields: 5 of 147
- Molecular Biology 938
- Oncology 888
- Epidemiology 737
- Genetics 627
- Pulmonary and Respiratory Medicine 544
Countries citing papers authored by David L. Cutler
This map shows the geographic impact of David L. Cutler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David L. Cutler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David L. Cutler more than expected).
Fields of papers citing papers by David L. Cutler
This network shows the impact of papers produced by David L. Cutler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David L. Cutler. The network helps show where David L. Cutler may publish in the future.
Co-authorship network of co-authors of David L. Cutler
This figure shows the co-authorship network connecting the top 25 collaborators of David L. Cutler. A scholar is included among the top collaborators of David L. Cutler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David L. Cutler. David L. Cutler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 12 | |
| 3 | 2 | |
| 4 | 11 | |
| 5 | 1 | |
| 6 | 72 | |
| 7 | 19 | |
| 8 | 2 | |
| 9 | 11 | |
| 10 | 76 | |
| 11 | 10 | |
| 12 | 10 | |
| 13 | 14 | |
| 14 | 49 | |
| 15 | 285 | |
| 16 | 91 | |
| 17 | Ezetimibe does not affect the pharmacokinetics of oral contraceptives | 27 |
| 18 | A Phase I trial of the farnesyl transferase inhibitor SCH66336: evidence for biological and clinical activity. | 201 |
| 19 | 3 | |
| 20 | 22 |
About David L. Cutler
David L. Cutler is a scholar working on Oncology, Hepatology and Hematology, having authored 145 papers that have together received 3.9k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (21 papers), Diabetes Treatment and Management (11 papers) and Antiplatelet Therapy and Cardiovascular Diseases (10 papers). The work is most often cited by research in Genetics (627 citations), Hepatology (406 citations) and Oncology (888 citations). David L. Cutler has collaborated with scholars based in United States, Argentina and United Kingdom. Frequent co-authors include Paul Statkevich, Teddy Kosoglou, Melton B. Affrime, Larisa Reyderman, Pascale Reidenberg, Eric K. Rowinsky, Margaret Dugan, Elaine Radwanski, Dasja Pajkrt and Tom van der Poll. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.